Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
about
Targeting BCL2-Proteins for the Treatment of Solid TumoursModeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.Occult breast tumor reservoir: biological properties and clinical significance.Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.The oestrogen paradox: an hypothesis.Molecular mechanisms of hormone resistance of breast cancer.Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA
P2860
Q26853686-94B473D6-C14F-46CF-8408-B1B58DAC71B1Q30370779-7B0A03C9-E07B-430E-BDCF-6FE7AE406D63Q30456637-1807B06C-5B4A-4AEE-B1C0-A52963F7B94EQ34502268-69A0FDE9-2124-48B5-8D28-CF8BBAAE49B0Q35827822-448CCEDD-723D-4B4A-99BA-ABF57C4324CCQ36011096-97EC23FD-FE5D-417A-AF41-5DD40FFE8E51Q36517144-EA714E9B-0C9D-4C0A-85D4-2C7815AC38ADQ37277121-9A824064-AC9D-4A98-AB80-F2D6A3B22EEAQ37376013-249052DE-16E9-42A1-9BF0-D9F95D7C114FQ39664547-AB557A1F-F422-4CB2-868C-E97C6A4B5EFFQ39675249-FBA6A1D7-98DF-4DC1-B698-61FC3D67A00DQ45788428-2381A361-5693-4FB8-8DBD-07EAD5862AB3Q53086084-7D95A44B-4DB2-48EC-BEC5-C83246815DD0Q57472758-33F9AA97-E50E-4223-8FA6-BF58FF118D6F
P2860
Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@ast
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@en
type
label
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@ast
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@en
prefLabel
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@ast
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@en
P2093
P1433
P1476
Down-regulation of Bcl-2 enhan ...... ted ER(+) breast cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10495-005-1903-2
P577
2005-05-01T00:00:00Z